|
Post by careful2invest on Feb 13, 2018 12:31:27 GMT -5
Mike's timing of this shot across the bow, seems to be more than ironic that it occurred after the hiring of Dave. It helps when you have a person with such a large footprint in the world of diabetes all of sudden right behind your backKendall gave Mike a spine? What you wrote sort of reads that way. I really think you are reading too much into this. Mike has consistently and long spoken out against high priced drugs and unethical pharma practices. And in his tweet, he was merely responding to an article as countless others did before and since. I did not read celo's post like you did mnkdfann. Mike C has already proven that he has a spine and balls, and a brain for that matter! Fortunately for MNKD and we investors, he now has the endorsement of one of, if not the best, individual that he could possibly have in his corner fighting the same fight! GLTA!
|
|
|
Post by celo on Feb 13, 2018 13:30:49 GMT -5
Aetna Medical Director (Aetna): Hello? Mike Castagna: Mike here from Mannkind, how’s it goin? Aetna: Who? From where? Mike: Michael Castagna?! You know, we have Afrezza! Aetna: Oh yeah, that inhalable stuff. Mike: You mind making the playing field a little more level for Afrezza like you did for all the injectables? Aetna: Inhalable is not the same as injectable. Mike: But we have a lot of patients that have had terrific outcomes using our product, why deny them the right? Aetna: Inhalable is just not as good. Mike: Hold on let me get someone, Dave you on? Dave: Hello this is Dr. David Kendall Aetna: The David Kendall that was at the ADA and has written all the papers? Dave: yep. Aetna: What are you doing at Mannkind, for the day? Just visiting? Dave: I work here, now. (Pause). Aetna: Oh. Dave: You know Afrezza is superior to all injectables in terms of speed? Aetna: But the inhale…. Dave: It’s safe. Aetna: lungs… Dave: Safe. Do I really need to bring up at the ADA how you are not allowing patients access to the most powerful drug to fight diabetes? Aetna: I, I, really don’t do much here. I just got a big bonus and a neat gold pen that writes really pretty. Do you want one Dave? Dave: No, just make Afrezza available. Mike: We cool now? Aetna: yeah we cool. Mike, you want a gold pen? CLICK
|
|
|
Post by mnkdfann on Feb 13, 2018 13:45:22 GMT -5
Aetna Medical Director (Aetna): Hello? Mike Castagna: Mike here from Mannkind, how’s it goin? Aetna: Who? From where? Mike: Michael Castagna?! You know, we have Afrezza! Aetna: Oh yeah, that inhalable stuff. Mike: You mind making the playing field a little more level for Afrezza like you did for all the injectables? Aetna: Inhalable is not the same as injectable. Mike: But we have a lot of patients that have had terrific outcomes using our product, why deny them the right? Aetna: Inhalable is just not as good. Mike: Hold on let me get someone, Dave you on? Dave: Hello this is Dr. David Kendall Aetna: The David Kendall that was at the ADA and has written all the papers? Dave: yep. Aetna: What are you doing at Mannkind, for the day? Just visiting? Dave: I work here, now. (Pause). Aetna: Oh. Dave: You know Afrezza is superior to all injectables in terms of speed? Aetna: But the inhale…. Dave: It’s safe. Aetna: lungs… Dave: Safe. Do I really need to bring up at the ADA how you are not allowing patients access to the most powerful drug to fight diabetes? Aetna: I, I, really don’t do much here. I just got a big bonus and a neat gold pen that writes really pretty. Do you want one Dave? Dave: No, just make Afrezza available. Mike: We cool now? Aetna: yeah we cool. Mike, you want a gold pen? CLICK Did Dave ever say word one about Afrezza BEFORE he was on MNKD's payroll? An earlier link shows than Mannkind (and a host of other Pharmas) sponsored a presentation he gave long ago, but he never mentioned Afrezza (or any other inhalable insulin) in it.
|
|
|
Post by celo on Feb 13, 2018 13:55:12 GMT -5
Aetna Medical Director (Aetna): Hello? Mike Castagna: Mike here from Mannkind, how’s it goin? Aetna: Who? From where? Mike: Michael Castagna?! You know, we have Afrezza! Aetna: Oh yeah, that inhalable stuff. Mike: You mind making the playing field a little more level for Afrezza like you did for all the injectables? Aetna: Inhalable is not the same as injectable. Mike: But we have a lot of patients that have had terrific outcomes using our product, why deny them the right? Aetna: Inhalable is just not as good. Mike: Hold on let me get someone, Dave you on? Dave: Hello this is Dr. David Kendall Aetna: The David Kendall that was at the ADA and has written all the papers? Dave: yep. Aetna: What are you doing at Mannkind, for the day? Just visiting? Dave: I work here, now. (Pause). Aetna: Oh. Dave: You know Afrezza is superior to all injectables in terms of speed? Aetna: But the inhale…. Dave: It’s safe. Aetna: lungs… Dave: Safe. Do I really need to bring up at the ADA how you are not allowing patients access to the most powerful drug to fight diabetes? Aetna: I, I, really don’t do much here. I just got a big bonus and a neat gold pen that writes really pretty. Do you want one Dave? Dave: No, just make Afrezza available. Mike: We cool now? Aetna: yeah we cool. Mike, you want a gold pen? CLICK Did Dave ever say word one about Afrezza BEFORE he was on MNKD's payroll? An earlier link shows than Mannkind (and a host of other Pharmas) sponsored a presentation he gave long ago, but he never mentioned Afrezza (or any other inhalable insulin) in it. Doesn't matter, worth it's weight in gold: "The research and clinical response to Afrezza as a mealtime insulin supports ongoing efforts to establish this product as the standard of care for those living with type 1 or type 2 diabetes," said Dr. Kendall. "Afrezza is the only inhaled fast-acting mealtime insulin on the market, and offers the right patients a flexible, safe, and effective treatment option. I'm thrilled to join MannKind, and look forward to being part of a company that has the potential to transform the lives of so many people that are living with diabetes."
|
|
|
Post by peppy on Feb 13, 2018 20:30:25 GMT -5
Aetna Medical Director (Aetna): Hello? Mike Castagna: Mike here from Mannkind, how’s it goin? Aetna: Who? From where? Mike: Michael Castagna?! You know, we have Afrezza! Aetna: Oh yeah, that inhalable stuff. Mike: You mind making the playing field a little more level for Afrezza like you did for all the injectables? Aetna: Inhalable is not the same as injectable. Mike: But we have a lot of patients that have had terrific outcomes using our product, why deny them the right? Aetna: Inhalable is just not as good. Mike: Hold on let me get someone, Dave you on? Dave: Hello this is Dr. David Kendall Aetna: The David Kendall that was at the ADA and has written all the papers? Dave: yep. Aetna: What are you doing at Mannkind, for the day? Just visiting? Dave: I work here, now. (Pause). Aetna: Oh. Dave: You know Afrezza is superior to all injectables in terms of speed? Aetna: But the inhale…. Dave: It’s safe. Aetna: lungs… Dave: Safe. Do I really need to bring up at the ADA how you are not allowing patients access to the most powerful drug to fight diabetes? Aetna: I, I, really don’t do much here. I just got a big bonus and a neat gold pen that writes really pretty. Do you want one Dave? Dave: No, just make Afrezza available. Mike: We cool now? Aetna: yeah we cool. Mike, you want a gold pen? CLICK hahaha. good one.
|
|
|
Post by falconquest on Feb 13, 2018 21:19:21 GMT -5
Did Dave ever say word one about Afrezza BEFORE he was on MNKD's payroll? An earlier link shows than Mannkind (and a host of other Pharmas) sponsored a presentation he gave long ago, but he never mentioned Afrezza (or any other inhalable insulin) in it. Doesn't matter, worth it's weight in gold: "The research and clinical response to Afrezza as a mealtime insulin supports ongoing efforts to establish this product as the standard of care for those living with type 1 or type 2 diabetes," said Dr. Kendall. "Afrezza is the only inhaled fast-acting mealtime insulin on the market, and offers the right patients a flexible, safe, and effective treatment option. I'm thrilled to join MannKind, and look forward to being part of a company that has the potential to transform the lives of so many people that are living with diabetes." Yup, that's it.....we got potential. Boy do we have potential! "Hey Joey, what's potential worth? Yeah, that's what I thought." Well, we got that goin' for us!
|
|
|
Post by brotherm1 on Feb 13, 2018 21:33:54 GMT -5
Wow! If when I was young and I would have spoken with a tongue so sharp and smart, my dad would have hit me with a back hand so hard my head would still be spinning around.
|
|
|
Post by olebob1 on Feb 13, 2018 21:49:47 GMT -5
Wow! If when I was young and I would have spoken with a tongue so sharp and smart, my dad would have hit me with a back hand so hard my head would still be spinning around. Who's tongue are you referring to?
|
|
|
Post by sellhighdrinklow on Feb 20, 2018 22:10:10 GMT -5
I was previously insured by Anthem BC up until, 12/31/17 when they discontinued coverage in California. In my research of which healthcare insurance company to sign up for, for 2018, I called Blue Shield and was told Afrezza IS covered but needs prior authorization. So, I signed up. When late January rolled around and it was close to needing to re-up my Afrezza delivery from Mankind's designated pharmacy, the pharmacy called me. I was surprised. I told the pharmacy representative, "Wow, I was about to call you, AB Cross no longer covers me and I'm now w Blue Shield of CA, just so you know". The pharmacy's reply was, "No problem sir, we just punch your name into our computer and your current insurance comes up." My deductible increased from $15 to $20. Smooth, no worries!! Fast forward to a few days ago when I opened a letter from Blue Shield, telling me they sent my Afrezza as a courtesy, blah, blah blah, not a preferred tier (or similar) and we "might" cover w prior authorization.... Castagna's tweet has me concerned. If a move from 6.7 A1C to 5.7 (latest) and fewer hypos isn't approved, I'll flip my lid. I'll update when I hear back. Update- Blue Shield is covering via Prior Authorization and assist from my Dr's Mannkind representative. The pharmacy is different but is now being administered from a local pharmacy via an app. It was a smooth transition, about 24-hours. I'm impressed and happy to be receiving my scheduled 90/4s + 90/8s Thursday!
|
|
|
Post by brotherm1 on Feb 20, 2018 22:47:17 GMT -5
EXCELLENT news SHDL. Very glad for you and thanks for passing it on!
|
|
|
Post by brotherm1 on Feb 20, 2018 23:45:59 GMT -5
|
|
|
Post by agedhippie on Feb 21, 2018 9:36:35 GMT -5
Amazon cover all insulin, including Afrezza, at the same tier and without prior authorization. That's interesting because their plan is administered by Express Scripts so they obviously are not using Express Scripts formulary which makes it a good example of a company directing it's PBM not to take the cheapest path.
|
|
|
Post by mnkdfann on Feb 21, 2018 9:40:45 GMT -5
Amazon cover all insulin, including Afrezza, at the same tier and without prior authorization. That's interesting because their plan is administered by Express Scripts so they obviously are not using Express Scripts formulary which makes it a good example of a company directing it's PBM not to take the cheapest path. Perhaps I missed a post, but how do you know Amazon coverage is as you described?
|
|
|
Post by agedhippie on Feb 21, 2018 10:18:54 GMT -5
Amazon cover all insulin, including Afrezza, at the same tier and without prior authorization. That's interesting because their plan is administered by Express Scripts so they obviously are not using Express Scripts formulary which makes it a good example of a company directing it's PBM not to take the cheapest path. Perhaps I missed a post, but how do you know Amazon coverage is as you described? From a friend who works for AWS. We even checked with Express Scripts because I didn't believe him.
|
|
|
Post by dreamboatcruise on Feb 21, 2018 12:35:09 GMT -5
Amazon cover all insulin, including Afrezza, at the same tier and without prior authorization. That's interesting because their plan is administered by Express Scripts so they obviously are not using Express Scripts formulary which makes it a good example of a company directing it's PBM not to take the cheapest path. Amazon may well be self insured, and the PBM is thus merely acting as a plan administrator. Especially in that situation, the PBM will pretty much put whatever drugs the company wants on the formulary. Doesn't surprise me that Amazon has top notch coverage. At their headquarters don't they provide unlimited custom made gourmet donuts delivered right to your desk... along with the insulin.
|
|